To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 304,851 shares, the number of shares held increased 23.46% compared to the previous period and now represents 1.24% of the total position.
      4.34KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 9,579 shares, the number of shares held decreased 0.35% compared to the previous period and now represents 1.71% of the total position.
      358Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-28 07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 27,050 shares, the number of shares held increased 1.19% compared to the previous period and now represents 2.18% of the total position.
      45Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-28 07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 15,330 shares, the number of shares held increased 1.19% compared to the previous period and now represents 1.26% of the total position.
      102Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-28 07:13
      ARKG Investment Tracker position change: Increased position in Natera by 2,970 shares, the number of shares held increased 1.19% compared to the previous period and now represents 4.03% of the total position.
      78Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-28 07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 20,840 shares, the number of shares held increased 1.19% compared to the previous period and now represents 2.26% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-28 07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 59,110 shares, the number of shares held increased 1.19% compared to the previous period and now represents 2.15% of the total position.
      26Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-28 07:13
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 7,230 shares, the number of shares held increased 1.19% compared to the previous period and now represents 1.85% of the total position.
      12Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-28 07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 11,860 shares, the number of shares held increased 1.19% compared to the previous period and now represents 1.58% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-28 07:13
      ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 5,640 shares, the number of shares held increased 1.19% compared to the previous period and now represents 3.75% of the total position.
      8Comment
      Report
       
       
       
       

      Most Discussed